<DOC>
	<DOCNO>NCT02128022</DOCNO>
	<brief_summary>Ischaemic heart disease common cause death UK . Glucagon-like peptide-1 ( GLP-1 ) demonstrate protect heart deprive blood supply ( ischaemia ) . The mechanism protection clear . Similar protection occur ischaemic condition heart , dependent potassium channel opening . The investigator intend establish whether GLP-1 mediate protection share similar mechanistic pathway . In order investigator measure pressure -- volume loop generate main pumping chamber heart time percutaneous coronary intervention ( stenting ) . Patients allocate GLP-1 alone , GLP-1 glibenclamide ( potassium channel block medication approve human use ) , saline control glibenclamide alone . The investigator hypothesis effect GLP-1 abrogate use glibenclamide .</brief_summary>
	<brief_title>Cardioprotective Effects GLP-1 Their Mechanisms</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>Age 18 Able give inform consent Elective percutaneous intervention single vessel coronary stenosis Normal leave ventricular function Severe Comorbidity Type 2 Diabetes Mellitus Nicorandil , Sulphonylureas , DPP4 inhibitor , GLP1 agonists Insulin use Women child bear age Myocardial infarction previous three month Previous coronary artery bypass graft</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Glucagon-Like Peptide 1</keyword>
	<keyword>Angina Pectoris</keyword>
	<keyword>Percutaneous Coronary Intervention</keyword>
	<keyword>Ischemic Preconditioning</keyword>
	<keyword>Myocardial Reperfusion Injury</keyword>
</DOC>